Tradestie Institutional Equity Comparison Engine

OTLK vs AVTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OTLK Overall Edge

OTLK Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Outlook Therapeutics, Inc. Common Stock (OTLK) driven by superior Valuation, Growth & Margin, Options & Structure while AVTX counters with relative strength in Momentum & Technical. Fundamentally, OTLK trades at 2.9x Forward P/E with 4781.8% operating margin (-99.4% YoY revenue) versus AVTX at N/M Forward P/E and -161962.7% operating margin (-69.3% YoY). In options structure, OTLK sits in BREAKDOWN (55th %ile IV; Dealer Gamma Walls on Pro) against AVTX sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner OTLK
OTLK 2.9x vs AVTX N/M Fwd P/E
Growth & Margin Winner OTLK
Op Margin 4781.8% vs -161962.7% ยท YoY -99.4% vs -69.3%
Momentum & Technical Winner AVTX
1Y -73.0% vs -50.2% ยท 52W Pos 10% vs 4%
Options & Structure Winner OTLK
BREAKDOWN (55th %ile IV) vs BREAKDOWN (16th %ile IV)
OTLK NASDAQ
Outlook Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.40
-4.04% 1D
Market Cap $107.1M
1M Return -18.82%
1Y Return -73.04%
Forward P/E 2.9x
Unified AI Score
48.6 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 71.0 Mom 64.0
AVTX NASDAQ
Avalo Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$7.33
-5.54% 1D
Market Cap $445.2M
1M Return -34.96%
1Y Return -50.24%
Forward P/E N/M
Unified AI Score
54.9 / 100 HOLD
Tech 65.0 Fund 68.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OTLK -73.04% AVTX -50.24% Spread: +22.8 pp (AVTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period OTLK Revenue AVTX Revenue OTLK Op. Margin AVTX Op. Margin Margin Edge
FY2018 $0M $10M -960.1% -503.4% AVTX
FY2019 $10M $10M -445.6% -239.1% AVTX
FY2020 N/A $10M N/A -1087.4% AVTX
FY2021 N/A $10M N/A -1521.6% AVTX
FY2022 N/A $20M N/A -207.4% AVTX
FY2023 N/A $0M N/A -1421.6% AVTX
FY2024 N/A $0M N/A -15535.6% AVTX
FY2025 $0M $0M -4744.3% -123601.7% OTLK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OTLK (6) vs AVTX (3)
Institutional Metric OTLK AVTX Criterion Row Winner
Market Capitalization Scale $107.1M $445.2M Larger Scale AVTX
Trailing P/E Ratio Valuation 2.9x N/M Lower Multiple OTLK
Forward P/E Ratio Valuation 2.9x N/M Lower Multiple OTLK
Revenue Growth (YoY) Growth -99.4% -69.3% Higher Growth AVTX
Operating Margin (TTM) Profitability 4781.8% -161962.7% Higher Margin OTLK
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -3.6% -33.6% Higher ROE OTLK
52-Week Range Position Momentum 10% ($0โ€“$3) 4% ($7โ€“$24) Stronger Trend OTLK
Beta / 30D Volatility Risk Regime 1.47ฮฒ ยท 79% Vol 1.70ฮฒ ยท 167% Vol Lower Realized Risk OTLK
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 54.9 / 100 (HOLD) Higher Composite AVTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OTLK vs AVTX Buy Guide
OTLK BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 55th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OTLK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVTX BREAKDOWN
133d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live AVTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OTLK nor AVTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.